DJ-1: A Potential Biomarker Related to Prognosis, Chemoresistance, and Expression of Microenvironmental Chemokine in HR-Positive Breast Cancer

Figure 3

Association between DJ-1 and clinical characteristics in HR+ breast cancer patients. (a) Kaplan–Meier overall survival curve of low and high DJ-1 expression group in 566 patients from TCGA HR+ breast cancer cohort; (b) Kaplan–Meier progression-free interval curve of low and high DJ-1 expression group in 566 patients from TCGA HR+ breast cancer cohort; (c) Kaplan–Meier overall survival curve of low and high DJ-1 expression group in 1,458 patients from METABRIC HR+ breast cancer cohort; (d) Kaplan–Meier relapse-free survival curve of low and high DJ-1 expression group in 1,458 patients from METABRIC HR+ breast cancer cohort.

(a)

(b)

(c)

(d)